Search results
Increases to CEO Compensation Might Be Put On Hold For Now at Barinthus Biotherapeutics plc...
Simply Wall St. via Yahoo Finance Canada· 2 months agoKey Insights Barinthus Biotherapeutics will host its Annual General Meeting on 10th of May Salary of...
Barinthus Biotherapeutics Reports Significant Financial Shifts and Clinical Progress in 2023
GuruFocus.com via Yahoo Finance Canada· 4 months agoRevenue: Dropped to $0.8 million in 2023 from $44.7 million in 2022, primarily due to decreased...
Will Barinthus Biotherapeutics (NASDAQ:BRNS) Spend Its Cash Wisely?
Simply Wall St. via Yahoo Finance Canada· 7 months agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Individual investors account for 48% of Barinthus Biotherapeutics plc's (NASDAQ:BRNS) ownership,...
Simply Wall St. via Yahoo Finance Canada· 4 months agoKey Insights The considerable ownership by individual investors in Barinthus Biotherapeutics...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 2 months agoArbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript May 2, 2024 Arbutus...
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance Canada· 4 months agoTango Therapeutics, Inc. (TNGX) delivered earnings and revenue surprises of -14.29% and 30.90%,...
Q3 2023 Arbutus Biopharma Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance Canada· 8 months agoParticipants David C. Hastings; CFO & CAO; Arbutus Biopharma Corporation Karen Sims; Chief Medical Officer; Arbutus Biopharma Corporation Lisa M. Caperelli; VP of IR; Arbutus Biopharma Corporation ...
Fed Speaks, Canada Inflation on Lineup Next Week
Baystreet via Yahoo Finance Canada· 4 months agoMonday U.S. Economic Lookahead Home builder confidence index (Feb.) Featured Earnings PDD Holdings Inc (NASDAQ:DD) (Q3) EPS of $1.44, compared to 97 cents in the prior-year quarter. Science ...
